11.45
0.26 (2.32%)
0.26 (2.32%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sangamo Therapeutics Inc | SGMO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.26 | 2.32% | 11.45 | 19:27:52 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 11.35 | 11.19 | 11.78 | 11.49 | 11.19 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 11.38 | 11.45 | 0.07 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 25,603 | 3,345,489 | $ 11.47 | $ 38,380,734 | 3,201,736 | 4.81 - 19.43 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:58:25 | formt | 360 | $ 11.45 | USD |
Sangamo Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.62B | 141.44M | 141.33M | $ 102.43M | $ -89.18M | -0.86 | -25.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Sangamo Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SGMO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 13.41 | 13.73 | 11.18 | 12.29 | 1,506,556 | -1.96 | -14.62% |
| 1 Month | 14.44 | 15.4543 | 11.18 | 13.51 | 1,481,817 | -2.99 | -20.71% |
| 3 Months | 9.92 | 19.43 | 9.05 | 14.57 | 2,443,171 | 1.53 | 15.42% |
| 6 Months | 11.27 | 19.43 | 9.05 | 12.88 | 1,866,263 | 0.18 | 1.6% |
| 1 Year | 6.77 | 19.43 | 4.81 | 10.71 | 2,129,116 | 4.68 | 69.13% |
| 3 Years | 25.00 | 26.90 | 4.81 | 12.10 | 1,984,518 | -13.55 | -54.2% |
| 5 Years | 5.16 | 27.50 | 2.65 | 11.57 | 1,649,525 | 6.29 | 121.9% |
Sangamo Therapeutics Description
| Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies. |
